A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability

scientific article

A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0000505
P932PMC publication ID2724707
P698PubMed publication ID19707280
P5875ResearchGate publication ID26767331

P2093author name stringBrett E Swierczewski
Stephen J Davies
P2860cites workGenomic analysis of the eukaryotic protein kinase superfamily: a perspectiveQ21092887
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classificationQ28131753
Oncogenic kinase signallingQ28189493
Tumor reversion: protein kinase A isozyme switchingQ28289952
Specificity and mechanism of action of some commonly used protein kinase inhibitorsQ28344791
Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug targetQ28469234
Two novel brain-specific splice variants of the murine Cbeta gene of cAMP-dependent protein kinaseQ28591623
Protein kinases as targets for anti-parasitic chemotherapyQ30828981
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.Q30883163
The phylogeny of the Schistosomatidae based on three genes with emphasis on the interrelationships of Schistosoma Weinland, 1858.Q30909660
SchistosomiasisQ33664589
The development and therapeutic potential of protein kinase inhibitorsQ33695725
Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinaseQ33904366
Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni.Q34001522
The many faces of H89: a reviewQ34600067
PraziquantelQ35156550
Implementation of national schistosomiasis control programmes in West AfricaQ36475694
Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.Q36922123
Protein tyrosine kinases as new potential targets against human schistosomiasisQ37006122
Protein kinases of malaria parasites: an updateQ37290712
The current status of drug discovery against the human kinomeQ37453498
cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymesQ37886477
cAMP-dependent protein kinase: role in normal and malignant growth.Q38289628
Modulation of blood fluke development in the liver by hepatic CD4+ lymphocytesQ38963507
Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.Q39096377
Herbimycin A suppresses mitotic activity and egg production of female Schistosoma mansoni.Q39141980
The involvement of cyclic adenosine monophosphate in the control of schistosome miracidium ciliaQ39225831
Forskolin: its biological and chemical propertiesQ39507081
The global epidemiological situation of schistosomiasis and new approaches to control and researchQ42007538
Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic targetQ42162203
The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytesQ43739315
Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID miceQ43868496
Early variations of host thyroxine and interleukin-7 favor Schistosoma mansoni developmentQ44218803
Inhibition of adenylate cyclase of catfish and rat hepatocyte membranes by 9-(tetrahydro-2-furyl)adenine (SQ 22536).Q44923441
Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.Q46631911
Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitorQ46833629
Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.Q54199827
Unhydrolyzable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cellsQ57424899
Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogsQ69343776
Possible roles of cAMP and Ca2+ in the regulation of miracidial transformation in Schistosoma mansoniQ69349953
Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor proteinQ69613011
Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinaseQ69679823
Adenylate cyclase in adults and cercariae of Schistosoma mansoniQ70233724
Laboratory induced resistance to praziquantel in experimental schistosomiasisQ72515762
Expression of multiple isoforms of the cAMP-dependent protein kinase (PK-A) catalytic subunit in the nematode, Caenorhabditis elegansQ79809418
P275copyright licenseCreative Commons CC0 LicenseQ6938433
P6216copyright statuscopyrighted, dedicated to the public domain by copyright holderQ88088423
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectinfectious diseaseQ18123741
cAMP dependent protein kinase catalytic subunitQ61632707
P304page(s)e505
P577publication date2009-08-25
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titleA schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability
P478volume3

Reverse relations

cites work (P2860)
Q21144514An atlas for Schistosoma mansoni organs and life-cycle stages using cell type-specific markers and confocal microscopy
Q28547348Application of RNAi to Genomic Drug Target Validation in Schistosomes
Q26824431Applications of RNA Interference in Schistosomiasis: Gene Function Identification and Development of New Therapies
Q34705415Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis.
Q40173400Conservation of protein kinase a catalytic subunit sequences in the schistosome pathogens of humans
Q90592084Deep phosphoproteome analysis of Schistosoma mansoni leads development of a kinomic array that highlights sex-biased differences in adult worm protein phosphorylation
Q36346161Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targets
Q33872700Developmental regulation of protein kinase A expression and activity in Schistosoma mansoni
Q33891612Eukaryotic protein kinases (ePKs) of the helminth parasite Schistosoma mansoni
Q33980222Exploring the function of protein kinases in schistosomes: perspectives from the laboratory and from comparative genomics
Q27305293Functional mapping of protein kinase A reveals its importance in adult Schistosoma mansoni motor activity
Q28479218Identification of Toxoplasma gondii cAMP dependent protein kinase and its role in the tachyzoite growth
Q35104325Identification, sequence analysis, and characterization of serine/threonine protein kinase 17A from Clonorchis sinensis
Q28539623Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects
Q64916694Molecular mechanisms of an antimicrobial peptide piscidin (Lc-pis) in a parasitic protozoan, Cryptocaryon irritans.
Q28710437New frontiers in schistosoma genomics and transcriptomics
Q37926614Paving the way for transgenic schistosomes
Q27306710RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening
Q38495042Re-positioning protein-kinase inhibitors against schistosomiasis
Q35570876Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery
Q28552326Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni
Q38625352Targeted overexpression of cyclic AMP-dependent protein kinase subunit in Toxoplasma gondii promotes replication and virulence in host cells.
Q22065287The draft genome of the carcinogenic human liver fluke Clonorchis sinensis
Q37955761The myriad roles of cyclic AMP in microbial pathogens: from signal to sword

Q61632707cAMP dependent protein kinase catalytic subunitdescribed by sourceP1343

Search more.